Quality Improvement
Quality improvement is central to achieving high-value care. Learn how we collaborate with all industry stakeholders to identify and bridge measurement gaps and advance patient care.
Avalere Enhances Market Access Capabilities with Additions
Avalere Health’s Market Access practice expands its team with recent hires bringing analytics, coverage strategy, and commercialization expertise.
Global Malnutrition Composite Score Included in IPPS Proposed Rule
The proposed inclusion of the Global Malnutrition Composite Score in the Hospital Inpatient Quality Reporting Program will enable hospitals and their patients to benefit from identifying and addressing malnutrition. The measure’s use facilitates high-quality and comprehensive nutrition care that begins in the inpatient setting and continues across transitions of care.
Cancer Moonshot Highlights Opportunities to Improve Cancer Care
On February 2, 2022, President Biden announced a revitalization of the Obama-era Cancer Moonshot Initiative, including updated goals to reduce cancer deaths by at least 50% over the next 25 years and improve the experience of cancer survivorship for patients and their families.
Avalere Adds Sarah Alwardt as New Practice Director
Sarah Alwardt joins Avalere as the practice director of the Center for Healthcare Transformation.
Webinar: Achieving Readiness for Radioligand Therapy in the US
Join leading clinicians and experts for a discussion of new policy recommendations for improving radioligand therapy readiness in the US.
Survey Shows Potential, Challenges, and Solutions for Broad PDT Access
A recent Pear Therapeutics–Avalere survey of 30 payers and 10 employer self-insured groups identified numerous insights to direct future efforts for broader adoption and coverage of prescription digital therapeutics (PDTs).
Prescription Digital Therapeutics Bring New Treatments to Healthcare
Prescription Digital Therapeutics (PDTs) are a growing and unique treatment modality that can provide expanded options for treatment to patients. As the landscape for these treatments develop across multiple therapeutic areas, challenges related to coverage, reimbursement, and access will need to be solved to advance broader adoption and utilization across key stakeholders.
Interview: Navigating Distribution and Third-Party Logistics, Part I
In this segment, our experts welcome leaders from Jazz Pharmaceuticals and Coherus BioSciences to discuss the selection process and key learnings and considerations for working with a third-party logistics (3PL) company.
Avalere Health Hires HEAA Researchers Joseph Tkacz and Jason Swindle
Duo joins as principals, bringing years of expertise in health economics and outcomes research.
Luke Reardon Brings Pharmacy Supply Chain Expertise to Avalere Health
Luke Reardon has joined Avalere’s Financial Services Practice as principal, bringing with him 15 years of experience that ranges from financial consulting to pharmacy solutions strategies.
Addressing the Diagnostic Journey for Rare Disease Patients
Avalere’s white paper draws on recommendations from a multi-stakeholder workshop to look at roadblocks and solutions for scaling sustainable solutions to address the diagnosis of rare disease.
Payer Survey Finds Opportunities for Renewed Focus on Mental Health
An Avalere survey of 37 decision-makers at risk-bearing payer entities identified shifting trends and focus for coverage of and access to behavioral health treatments and services.
Interview: Huntington’s Disease: Challenges and Treatment
Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, our experts from the Center for Healthcare Transformation discuss Huntington’s Disease, its impact on caregivers, the complexities of genetic testing, and potential treatment options for this rare disorder.
Video: Huntington’s Disease: Challenges and Treatment
Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, our experts from the Center for Healthcare Transformation discuss Huntington’s Disease, its impact on caregivers, the complexities of genetic testing, and potential treatment options for this rare disorder.
Advancing Diabetes Care in the Era of CGM: Dialogue Proceedings
As one of the most common chronic conditions in the US—affecting approximately 10.5% of the US population and growing—diabetes (and the optimal management of this condition) remain a persistent healthcare challenge.1
Video: Malnutrition and Quality Improvement
Tune into another episode of Avalere Health Essential Voice. In this segment of our Disease Education series, experts from our Center for Healthcare Transformation discuss the burden of malnutrition on our healthcare system and how an Avalere-led quality improvement initiative has helped systems across the country improve malnutrition identification and treatment.
Interview: Malnutrition and Quality Improvement
Tune into another episode of Avalere Health Essential Voice. In this segment of our Disease Education series, experts from our Center for Healthcare Transformation discuss the burden of malnutrition on our healthcare system and how an Avalere-led quality improvement initiative has helped systems across the country improve malnutrition identification and treatment.
RWE Strategy Leads to Support for Avalere-Developed Composite Measure
Avalere was pleased to partner with the nutrition community to develop and test the Global Malnutrition Composite Score, which has now received conditional support from the Measure Applications Partnership (MAP)—pending endorsement by the National Quality Forum (NQF)—for inclusion in the Hospital Inpatient Quality Reporting (IQR) Program.
Accelerating Evidence-Based Nutrition Practice
On November 3, the Journal of the Academy of Nutrition and Dietetics published an article entitled “Implementation Science in Evidence-Based Nutrition Practice: Considerations for the Registered Dietitian Nutritionist,” co-authored by Christina Badaracco.
Just Launched: Implementation Guide for the First Hypoglycemia Measures
In December 2019, Avalere Health and Endocrine Society launched the first quality measurement set designed to help providers assess how well they identify and care for older adults at greater risk of hypoglycemia – low blood sugar that can be a dangerous complication of diabetes.